{"title":"90 Y放射栓塞治疗肝脏肿瘤的并发症分析","authors":"Mason Eghbali, Z. Haber, R. Srinivasa, S. Padia","doi":"10.1055/s-0043-1760730","DOIUrl":null,"url":null,"abstract":"Abstract Y90 radioembolization has been demonstrated to be a safe and effective treatment for patients with HCC and for certain liver metastases, such as neuroendocrine tumors, uveal melanomas, and breast cancer. Although the procedure is relatively safe, the complications associated with radioembolization vary greatly in their locations, presentation, and severity. This review aims to discuss and increase awareness of the potential complications associated with radioembolization.","PeriodicalId":91014,"journal":{"name":"Digestive disease interventions","volume":"58 1","pages":"138 - 144"},"PeriodicalIF":0.0000,"publicationDate":"2022-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Complications of 90 Y Radioembolization Treatment for Liver Tumors\",\"authors\":\"Mason Eghbali, Z. Haber, R. Srinivasa, S. Padia\",\"doi\":\"10.1055/s-0043-1760730\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Abstract Y90 radioembolization has been demonstrated to be a safe and effective treatment for patients with HCC and for certain liver metastases, such as neuroendocrine tumors, uveal melanomas, and breast cancer. Although the procedure is relatively safe, the complications associated with radioembolization vary greatly in their locations, presentation, and severity. This review aims to discuss and increase awareness of the potential complications associated with radioembolization.\",\"PeriodicalId\":91014,\"journal\":{\"name\":\"Digestive disease interventions\",\"volume\":\"58 1\",\"pages\":\"138 - 144\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-10-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Digestive disease interventions\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1055/s-0043-1760730\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Digestive disease interventions","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0043-1760730","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Complications of 90 Y Radioembolization Treatment for Liver Tumors
Abstract Y90 radioembolization has been demonstrated to be a safe and effective treatment for patients with HCC and for certain liver metastases, such as neuroendocrine tumors, uveal melanomas, and breast cancer. Although the procedure is relatively safe, the complications associated with radioembolization vary greatly in their locations, presentation, and severity. This review aims to discuss and increase awareness of the potential complications associated with radioembolization.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
